Coherus Biosciences Appoints Lisa M. Bell, Ph.D., Senior Vice President, Global Regulatory Affairs - 21 News Now, More Local News for Youngstown, Ohio -

Coherus Biosciences Appoints Lisa M. Bell, Ph.D., Senior Vice President, Global Regulatory Affairs

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Coherus Biosciences, Inc.

REDWOOD CITY, Calif., May 12, 2014 /PRNewswire/ -- Coherus Biosciences, Inc. ("Coherus"), is pleased to announce the appointment of Lisa M. Bell, Ph.D. as Senior Vice President, Global Regulatory Affairs.  Dr. Bell joins Coherus with more than 15 years of experience in global regulatory affairs and drug development across various therapeutic areas at preeminent biotech companies.

"Lisa brings a strong strategic, scientific and global mindset to the regulatory strategy for our programs," said Denny Lanfear, President and CEO of Coherus.  "We are thrilled to have her join Coherus. Lisa's experience in overseeing global applications to approval and implementing cutting-edge regulatory strategies will be critical as we strive to obtain approved labels for ourselves and our partners."

"I am extremely pleased to join the extraordinary team at Coherus and share their commitment to deliver high-quality biosimilar therapeutics that will expand patient access to life-changing medicines worldwide." said Dr. Bell.

Dr. Bell most recently served as global head of Regulatory, Pharmacovigilance, Medical Writing and Development Quality Assurance at BioMarin Pharmaceutical. Previously she also held leadership roles at Facet Biotech and Genentech, Inc. Dr. Bell has extensive experience in driving regulatory strategy of large and small molecule programs from pre-clinical through post-marketing phases of development. She has worked across several therapeutic areas including oncology, neurology/inflammation and rare diseases. Dr. Bell earned her Bachelors (Biology) and Masters (Biotechnology) degrees from Boston University and a Ph.D. in Molecular and Cell Biology from the University of California, Berkeley.

About Coherus Biosciences

Coherus Biosciences is a leading biologics platform company focused on delivering high-quality biosimilar therapeutics that will expand patient access to life-changing medications worldwide. Headquartered in the San Francisco Bay Area and founded by a group of biotech pioneers who helped build America's first generation biotherapeutics industry, Coherus has developed a unique, collaborative business model that leverages a strategic consortium of key service providers aligned through ownership and shared incentives.  Coherus' global commercialization partnerships include top tier biopharma companies in Europe, Asia, and Latin America.

Biosimilars are intended for use in place of existing, branded biologics to treat a range of chronic and often life-threatening diseases, with the potential to reduce costs and expand patient access.  For additional information, please visit www.coherus.com.

Contact – Beth Jimisonbjimison@coherus.com  650.649.3526

Coherus BioSciences Logo.

Logo - http://photos.prnewswire.com/prnh/20120507/SF01448LOGO

©2012 PR Newswire. All Rights Reserved.

  • More From wfmj.comMore>>

  • Group honors third Kennywood coaster as 'landmark'

    Group honors third Kennywood coaster as 'landmark'

    Monday, July 28 2014 9:07 AM EDT2014-07-28 13:07:05 GMT
    The group American Coaster Enthusiasts has named the Thunderbolt a "Coaster Landmark" - the third roller coaster to be so recognized at the Kennywood amusement park near Pittsburgh.More >>
    The group American Coaster Enthusiasts has named the Thunderbolt a "Coaster Landmark" - the third roller coaster to be so recognized at the Kennywood amusement park near Pittsburgh.
    More >>
  • Ohio offers extra hunting days for mourning doves

    Ohio offers extra hunting days for mourning doves

    Sunday, July 27 2014 1:45 PM EDT2014-07-27 17:45:29 GMT
    Ohio will allow extra days for hunting mourning doves this year.More >>
    Ohio will allow extra days for hunting mourning doves this year.
    More >>
  • Ohio authorities say 2 killed in small plane crash

    Ohio authorities say 2 killed in small plane crash

    Sunday, July 27 2014 1:38 PM EDT2014-07-27 17:38:30 GMT
    FINDLAY, Ohio (AP) - Authorities in northwest Ohio say two people have been killed in an overnight small plane crash. The Hancock County sheriff's office says the crash apparently occurred at about 1 a.m. EDT Sunday. Investigators were still at the scene Sunday and little other information was available immediately. The plane crashed near a county road just northeast of the city of Findlay. The city has a small general aviation airport, but authorities were still investigating where the plan...More >>
    FINDLAY, Ohio (AP) - Authorities in northwest Ohio say two people have been killed in an overnight small plane crash. The Hancock County sheriff's office says the crash apparently occurred at about 1 a.m. EDT Sunday. Investigators were still at the scene Sunday and little other information was available immediately. The plane crashed near a county road just northeast of the city of Findlay. The city has a small general aviation airport, but authorities were still investigating where the plan...More >>
Powered by WorldNow
All content © Copyright 2000 - 2014 Worldnow and WFMJ. All Rights Reserved. For more information on this site, please read our Privacy Policy and Terms